Imidazole-1-Carboxylic Acid Phenylamide

Imidazole-1-Carboxylic Acid Phenylamide

SCHEMBL10668282

O=C(Nc1ccccc1)n1ccnc1

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
KDM4E B2RXH2 1/20 0.50
ALDH1A1 P00352 1/20 0.50
TAAR1 Q96RJ0 1/20 0.49
GAA P10253 1/20 0.48
HTT P42858 1/20 0.46
CYP3A4 P08684 2/20 0.46
TSHR P16473 2/20 0.46
NPC1 O15118 1/20 0.45
PKM P14618 1/20 0.45
TP53 P04637 1/20 0.44
EPHX1 P07099 1/20 0.44
EPHX2 P34913 1/20 0.44
CDK9 P50750 1/20 0.44
CLK4 Q9HAZ1 1/20 0.44
CYP1A2 P05177 1/20 0.44
FAAH O00519 1/20 0.43
MGLL Q99685 1/20 0.43
NAMPT P43490 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24001003 0.88 MDM2 (0.52) RAB9AKDM4ETAAR1GAAHTT
SCHEMBL10662756 0.86 GAA (0.45) ALDH1A1GAACYP3A4TSHR
SCHEMBL24000883 0.85 RAB9A (0.53) RAB9ASMN1; SMN2KDM4EALDH1A1CYP3A4
SCHEMBL10662282 0.85 KMT2A (0.53) RAB9AKDM4EALDH1A1GAACYP3A4
SCHEMBL31402684 0.83 TSHR (0.51) RAB9AALDH1A1TSHRNPC1TP53
SCHEMBL11767236 0.82 KMT2A (0.56) RAB9ASMN1; SMN2ALDH1A1GAAHTT
SCHEMBL9913370 0.81 KDM4E (0.44) RAB9ASMN1; SMN2KDM4EALDH1A1TAAR1
SCHEMBL18184936 0.81 CYP19A1 (0.56) RAB9AKDM4EALDH1A1GAAHTT
SCHEMBL30879899 0.81 SMN1; SMN2 (0.50) RAB9ASMN1; SMN2KDM4EALDH1A1GAA
SCHEMBL21843382 0.80 HTT (0.58) RAB9ASMN1; SMN2KDM4EALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119799155-A Low-salt-water-invasion metal anti-salty coating structure and construction method thereof 平陆运河集团有限公司 2025-04-11 CN claimed
CN-112250840-B Low-temperature rapid gelling anti-yellowing molding powder and preparation method thereof 潍坊泉源新材料科技有限公司 2023-03-24 CN claimed
CN-113736349-B Corrosion-resistant epoxy resin coating and preparation method thereof 安徽华辉塑业科技股份有限公司 2022-05-17 CN claimed
CN-113736349-A Corrosion-resistant epoxy resin coating and preparation method thereof 安徽华辉塑业科技股份有限公司 2021-12-03 CN claimed
CN-112250840-A Low-temperature rapid gelling anti-yellowing molding powder and preparation method thereof 潍坊泉源新材料科技有限公司 2021-01-22 CN claimed
CN-104402813-B Novel method for synthesizing sorafenib 哈药集团制药总厂 2017-05-10 CN claimed
CN-104448273-B A kind of indoor physics extinction type saturated polyester resin and preparation method thereof and coating 泰兴市华盛银洋新材料科技有限公司 2016-10-26 CN claimed
EP-3949000-B1 LITHIUM BATTERY COMPRISING A UREA-BASED COMPOUND AS ELECTROLYTE ADDITIVE BAYERISCHE MOTOREN WERKE AG (DE) 2025-04-30 EP disclosed
CN-119799155-A Low-salt-water-invasion metal anti-salty coating structure and construction method thereof 平陆运河集团有限公司 2025-04-11 CN disclosed
CN-114026729-B Lithium battery and use of urea-based additive as electrolyte additive therein 宝马股份公司 2024-02-13 CN disclosed
CN-112250840-B Low-temperature rapid gelling anti-yellowing molding powder and preparation method thereof 潍坊泉源新材料科技有限公司 2023-03-24 CN disclosed
CN-112250840-B Low-temperature rapid gelling anti-yellowing molding powder and preparation method thereof 潍坊泉源新材料科技有限公司 2023-03-24 CN disclosed
CN-113248449-B Aryl spiro-compound containing formamidine and preparation method and application thereof 中国药科大学 2022-09-23 CN disclosed
US-20120219905-A1 RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-08-30 US disclosed
US-20120219905-A1 RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-08-30 US disclosed
US-20100234377-A1 PIPERAZINE COMPOUNDS FOR THE INHIBITION OF HAEMATOPOIETIC PROSTAGLANDIN D SYNTHASE EVOTEC AG (DE) 2010-09-16 US disclosed
US-20080021029-A1 Substituted Cyclic Urea Derivatives, Preparation Thereof And Pharmaceutical Use Thereof As Kinase Inhibitors AVENTIS PHARMA S.A. (FR) 2008-01-24 US disclosed
US-4749729-A MONO- AND DI-IMIDAZOLE CARBOXAMIDES AMERICAN CYANAMID COMPANY (US) 1988-06-07 US disclosed
US-4487914-A METAL SALT COMPLEX OF AN ADDUCT OF AN IMIDAZOLE AND A MONOFUNCTIONAL EPOXY COMPOUND NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1984-12-11 US disclosed
EP-0117113-A2 Curing agents for epoxy resins BTG INTERNATIONAL LIMITED (GB) 1984-08-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234377-A1 PIPERAZINE COMPOUNDS FOR THE INHIBITION OF HAEMATOPOIETIC PROSTAGLANDIN D SYNTHASE HPGDS, PTGDR, PTGIS RAB9A 2884/4885SMN1; SMN2 1866/4885KDM4E 3580/4885
US-20080021029-A1 Substituted Cyclic Urea Derivatives, Preparation Thereof And Pharmaceutical Use Thereof As Kinase Inhibitors PRKAR2B, PRKG2, PRKG1 RAB9A 1233/4885SMN1; SMN2 4664/4885KDM4E 1807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.